File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

강세병

Kang, Sebyung
Protein Nanobio Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Versatile Bioconjugated Affibody-glutathione Transferase Protein Gate Keeper for Drug Delivery Nanoparticle

Author(s)
Oh, Jun YongPalanikumar, LLho, YunmeeKim, Han SolKim, Ho-youngJoo, Sang HoonHa, EunyoungKang, SebyungRyu, Ja-Hyoung
Issued Date
2016-10-04
URI
https://scholarworks.unist.ac.kr/handle/201301/39920
Fulltext
http://www.dbpia.co.kr/Journal/ArticleDetail/NODE07048803
Citation
IUPAC-PSK40 (International Conference on Advanced Polymeric Materials)
Abstract
Among the drug delivery carriers, mesoporous silica nanoparticles (MSN) have received wide attention due to their tunable pore morphology, high specific surface area, easy surface modification/ bioconjugation for targeting and physiochemical stability. They can host the therapeutic compounds due their void cores, as extra reservoir for drug storage. Also gatekeeper system can maximize the characterization of MSN for being used drug delivery systems. Although there are many kinds of gatekeeper systems ,like polymer, peptide, metal nanoparticles, not much improve in protein gate keeper. Protein gate keeper could be one of the most powerful platform by using direct interaction between receptor protein and affibody. Also our GST-affibody protein forms protein layer which can shield inside silica nanoparticle from unwished human serum protein (protein corona) Drug can be loaded into the pores of the carrier at large quantity. Recently, non-covalent protein gatekeepers have received significant attention towards encapsulation stability. Hence, we installed a biocompetable protein gatekeepers on the surface of drug loaded carriers. The GST-affibody possess important role in undergoing degradation in low pH. Further, this affibody can be conjugated with different types of antibody to target specific cancer cells to achieve a stable and biocompatible carrier for biomedical applications.
Publisher
IUPAC-한국고분자학회

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.